GlassScriptPhysician profile
Anthony R Vara
NPI 1093797482
$4,237.34
in general payments reported to CMS, 2019-2025
32 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2021: $273 · 2022: $757 · 2023: $956 · 2024: $840 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525 · Education: $180 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,525.47 |
| Education | $179.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $584.54 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $543.36 | 2019-2025 | Myrbetriq, Veozah, Xtandi |
| Janssen Biotech, INC. | $445.45 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $383.19 | 2019-2025 | |
| Axonics, INC. | $375.96 | 2022-2023 | Axonics |
| Medtronic, INC. | $230.93 | 2022-2023 | Interstim |
| Boston Scientific Corporation | $227.83 | 2019-2025 | Ams 700, Advantage System, Axonics |
| Photocure INC | $146.05 | 2019-2023 | Cysview |
| Teleflex LLC | $144.14 | 2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $137.14 | 2022-2025 | Prolaris |
| Procept Biorobotics Corporation | $116.55 | 2022 | |
| Abbvie INC. | $90.17 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $88.40 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $68.72 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $59.78 | 2024 | Keytruda, Welireg |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $57.35 | 2022-2023 | Supris |
| Dendreon Pharmaceuticals LLC | $55.41 | 2025 | Provenge |
| Tolmar, INC. | $53.23 | 2023-2025 | Jatenzo, Eligard |
| C. R. Bard, INC. & Subsidiaries | $53.19 | 2023 | Bard Urinary Drainage Bag |
| Allergan, INC. | $47.24 | 2021 | |
| Endo Pharmaceuticals INC. | $44.14 | 2022-2023 | Aveed, Edex, Xiaflex |
| Urovant Sciences INC | $38.71 | 2022 | |
| Laborie Medical Technologies Corp. | $35.56 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $34.98 | 2021-2022 | |
| Ethicon US, LLC | $27.68 | 2023 | Certus 140 |
| Urogen Pharma, INC. | $25.17 | 2025 | |
| Myovant Sciences INC. | $25.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.18 | 2025 | |
| Progenics Pharmaceuticals, INC. | $22.24 | 2024 | |
| Tempus Ai, INC | $21.52 | 2024 | Xt Cdx |
| 180 Medical, INC. | $18.85 | 2024 | Gentlecath |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Vara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.